{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:49:35Z","timestamp":1791013775380,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.neuropharm.2009.12.010","type":"journal-article","created":{"date-parts":[[2009,12,25]],"date-time":"2009-12-25T09:11:07Z","timestamp":1261732267000},"page":"758-766","source":"Crossref","is-referenced-by-count":48,"title":["Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain"],"prefix":"10.1016","volume":"58","author":[{"given":"Aldric T.","family":"Hama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Sagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2009.12.010_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1527-3458.2006.00250.x","article-title":"Paracetamol: new vistas of an old drug","volume":"12","author":"Bertolini","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10790268.2006.11753864","article-title":"Treatments for chronic pain in persons with spinal cord injury: a survey study","volume":"29","author":"Cardenas","year":"2006","journal-title":"J. Spinal Cord Med."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(96)00629-2","article-title":"Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors","volume":"315","author":"Catheline","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12272-009-1139-8","article-title":"Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats","volume":"32","author":"Chen","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1196\/annals.1414.033","article-title":"Cancer pain and analgesia","volume":"1138","author":"Christo","year":"2008","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s002100100484","article-title":"Effects of acetaminophen on monoaminergic systems in the rat central nervous system","volume":"364","author":"Courade","year":"2001","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejphar.2007.07.012","article-title":"The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors","volume":"573","author":"Dani","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/0024-3205(74)90092-7","article-title":"Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen","volume":"14","author":"Davis","year":"1974","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.051","article-title":"Pharmacological characterization of the chronic constriction injury model of neuropathic pain","volume":"491","author":"De Vry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.0703303","article-title":"Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine\/chemokines and PMN","volume":"75","author":"Di Filippo","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1682\/JRRD.2008.04.0053","article-title":"Prevalence of chronic pain after traumatic spinal cord injury: a systematic review","volume":"46","author":"Dijkers","year":"2009","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-6576.2006.01237.x","article-title":"The post-operative analgesic effects of a combination of gabapentin and paracetamol in patients undergoing abdominal hysterectomy: a randomized clinical trial","volume":"51","author":"Durmus","year":"2007","journal-title":"Acta Anaesthesiol Scand."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1351-5101.2003.00725.x","article-title":"Spinal cord injury pain\u2013mechanisms and treatment","volume":"11","author":"Finnerup","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/bjp.2008.175","article-title":"The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors","volume":"154","author":"da Fonseca Pacheco","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0361-9230(03)00103-5","article-title":"The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801","volume":"61","author":"Forman","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nbd.2008.09.015","article-title":"The endocannabinoid system is modulated in response to spinal cord injury in rats","volume":"33","author":"Garcia-Ovejero","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1586\/14737175.5.6.823","article-title":"Combination pharmacotherapy for neuropathic pain: current evidence and future directions","volume":"5","author":"Gilron","year":"2005","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1213\/ane.0b013e3181733ddd","article-title":"Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient","volume":"107","author":"Grande","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2008.08.005","article-title":"Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase","volume":"600","author":"Haller","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2006.11.047","article-title":"Altered antinociceptive efficacy of tramadol over time in rats with painful peripheral neuropathy","volume":"559","author":"Hama","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.expneurol.2006.09.002","article-title":"Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury","volume":"204","author":"Hama","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2007.09.013","article-title":"Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression","volume":"1185","author":"Hama","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3959(00)00425-5","article-title":"The antinociceptive effect of intrathecal administration of epibatidine with clonidine or neostigmine in the formalin test in rats","volume":"91","author":"Hama","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1471-4159.1998.70020671.x","article-title":"Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission","volume":"70","author":"Hampson","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","article-title":"The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain","volume":"221","author":"Herzberg","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib28","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":"Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system","volume":"280","author":"Hogestatt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-3084(02)00154-8","article-title":"Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives","volume":"121","author":"Hohmann","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib30","article-title":"Mechanisms of chronic central neuropathic pain after spinal cord injury","author":"Hulsebosch","year":"2008","journal-title":"Brain Res. Rev"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pain.2005.12.018","article-title":"CB2 cannabinoid receptor mediation of antinociception","volume":"122","author":"Ibrahim","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib33","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.290.13.1757","article-title":"Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial","volume":"290","author":"Karst","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/AJP.0b013e318158ed9e","article-title":"Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?","volume":"24","author":"Knotkova","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.genhosppsych.2008.12.006","article-title":"Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews","volume":"31","author":"Kroenke","year":"2009","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib36","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1124\/jpet.105.100792","article-title":"Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]","volume":"317","author":"La Rana","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pain.2004.01.022","article-title":"Mice lacking fatty acid\u00a0iamide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia","volume":"109","author":"Lichtman","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2004.03.010","article-title":"Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model","volume":"110","author":"Lynch","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pain.2008.03.030","article-title":"Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia","volume":"139","author":"Mallet","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib40","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2165\/00003495-200363110-00007","article-title":"Tramadol\/paracetamol","volume":"63","author":"McClellan","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pain.2006.06.016","article-title":"Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain","volume":"126","author":"Mitrirattanakul","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1471-4159.2005.03462.x","article-title":"Transcriptional profiling of spinal cord injury-induced central neuropathic pain","volume":"95","author":"Nesic","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AJP.0b013e31818a744d","article-title":"Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Norrbrink","year":"2009","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1476-5381.2009.00310.x","article-title":"Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor","volume":"158","author":"Pacheco Dda","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjp.0705297","article-title":"Actions of tramadol on micturition in awake, freely moving rats","volume":"139","author":"Pandita","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib46","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-3565(24)36432-8","article-title":"Naloxone-reversible antinociception by paracetamol in the rat","volume":"280","author":"Pini","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0014-2999(90)90190-H","article-title":"Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction","volume":"179","author":"Porreca","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00045391-200007020-00007","article-title":"Therapeutic misadventure with paracetamol: fact or fiction?","volume":"7","author":"Prescott","year":"2000","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0079-6123(05)52017-X","article-title":"Segmental organization of spinal reflexes mediating autonomic dysreflexia after spinal cord injury","volume":"152","author":"Rabchevsky","year":"2006","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib51","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1517\/14656566.4.10.1697","article-title":"Combination strategies for pain management","volume":"4","author":"Raffa","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)11227-5","article-title":"Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an \u2018atypical\u2019 opioid analgesic","volume":"260","author":"Raffa","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)38900-1","article-title":"Discovery of \u201cself-synergistic\u201d spinal\/supraspinal antinociception produced by acetaminophen (paracetamol)","volume":"295","author":"Raffa","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib54","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(01)00722-1","article-title":"Unexpected and pronounced antinociceptive synergy between spinal acetaminophen (paracetamol) and phentolamine","volume":"412","author":"Raffa","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib55","first-page":"186","article-title":"Management of pain in persons with spinal cord injury","volume":"20","author":"Ragnarsson","year":"1997","journal-title":"J.\u00a0Spinal Cord Med."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib56","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3171\/spi.2007.6.5.420","article-title":"Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats","volume":"6","author":"Rajpal","year":"2007","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib57","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cbdv.200790150","article-title":"Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine","volume":"4","author":"Russo","year":"2007","journal-title":"Chem. Biodivers"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.107.119941","article-title":"The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice","volume":"322","author":"Russo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib59","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/10790268.2000.11753532","article-title":"Use of capsaicin in the treatment of radicular pain in spinal cord injury","volume":"23","author":"Sandford","year":"2000","journal-title":"J. Spinal Cord Med."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.sc.3101824","article-title":"A proposed algorithm for the management of pain following spinal cord injury","volume":"44","author":"Siddall","year":"2006","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib61","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.lfs.2005.06.024","article-title":"Analysis of interaction between etoricoxib and tramadol against mechanical hyperalgesia of spinal cord injury in rats","volume":"78","author":"Singh","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-3057(98)00012-4","article-title":"The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol","volume":"60","author":"Smith","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00314972","article-title":"Lack of effect of paracetamol on the pharmacokinetics and metabolism of codeine in man","volume":"41","author":"Somogyi","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00555519","article-title":"Therapeutic doses of codeine have no effect on acetaminophen clearance or metabolism","volume":"35","author":"Sonne","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pharmthera.2006.08.002","article-title":"Interactions between drugs and occupied receptors","volume":"113","author":"Tallarida","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib67","series-title":"Manual of Pharmacological Calculations with Computer Programs","author":"Tallarida","year":"1981"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib68","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0024-3205(89)90148-3","article-title":"Statistical analysis of drug-drug and site-site interactions with isobolograms","volume":"45","author":"Tallarida","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib69","first-page":"23","article-title":"Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram","volume":"58","author":"Tallarida","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/faat.1996.0038","article-title":"Sex- and age-dependent acetaminophen hepato- and nephrotoxicity in Sprague-Dawley rats: role of tissue accumulation, nonprotein sulfhydryl depletion, and covalent binding","volume":"30","author":"Tarloff","year":"1996","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib71","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjp.0706045","article-title":"Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice","volume":"144","author":"Tham","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0304-3959(97)00041-9","article-title":"Drug interactions in human neuropathic pain pharmacotherapy","volume":"73","author":"Virani","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib73","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000542-200501000-00024","article-title":"Changes in properties of spinal dorsal horn neurons and their sensitivity to morphine after spinal cord injury in the rat","volume":"102","author":"Wang","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib74","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-3565(24)37725-0","article-title":"Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A","volume":"286","author":"Welch","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib75","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1682\/JRRD.2008.12.0162","article-title":"Pain: a multidimensional problem of national priority","volume":"46","author":"Widerstrom-Noga","year":"2009","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib76","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/sj.sc.3101511","article-title":"Types and effectiveness of treatments used by people with chronic pain associated with spinal cord injuries: influence of pain and psychosocial characteristics","volume":"41","author":"Widerstrom-Noga","year":"2003","journal-title":"Spinal Cord"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroscience.2005.06.009","article-title":"Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons","volume":"135","author":"Wotherspoon","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(03)00245-8","article-title":"Topical cannabinoid enhances topical morphine antinociception","volume":"105","author":"Yesilyurt","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2009.12.010_bib79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1682\/JRRD.2008.06.0074","article-title":"Spinal cord injury pain: spinal and supraspinal mechanisms","volume":"46","author":"Yezierski","year":"2009","journal-title":"J.\u00a0Rehabil. Res. Dev."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(93)90656-6","article-title":"The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat","volume":"157","author":"Yezierski","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2009.12.010_bib81","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-4804(02)96481-4","article-title":"Change of vanilloid receptor 1 following neuromodulation in rats with spinal cord injury","volume":"107","author":"Zhou","year":"2002","journal-title":"J. Surg. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809003761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809003761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T11:08:01Z","timestamp":1739704081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390809003761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":81,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0028390809003761"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2009.12.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}